Ownership history in Squarepoint Ops LLC · 54 quarters on record
This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in ARRAY BIOPHARMA INC (ARRY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 51,300 | -404,069 | -88.7% | 0.00% | $418K | $8.15 |
| 2025 Q3 | ADDED | 455,369 | +304,669 | +202.2% | 0.00% | $3.7M | $8.15 |
| 2025 Q3 | REDUCED | 150,700 | -381,222 | -71.7% | 0.00% | $1.2M | $8.15 |
| 2025 Q2 | ADDED | 531,922 | +380,922 | +252.3% | 0.00% | $3.1M | $5.90 |
| 2025 Q2 | ADDED | 151,000 | +138,200 | +1079.7% | 0.00% | $891K | $5.90 |
| 2025 Q2 | REDUCED | 12,800 | -1,006,402 | -98.7% | 0.00% | $76K | $5.90 |
| 2025 Q1 | ADDED | 1,019,202 | +963,102 | +1716.8% | 0.01% | $5.0M | $4.87 |
| 2025 Q1 | REDUCED | 56,100 | -149,600 | -72.7% | 0.00% | $273K | $4.87 |
| 2024 Q4 | REDUCED | 205,700 | -94,197 | -31.4% | 0.00% | $1.2M | $6.04 |
| 2024 Q4 | ADDED | 299,897 | +270,997 | +937.7% | 0.00% | $1.8M | $6.04 |
As of 2025 Q4 — sorted by position size